Keywords: nih, initiates, ph, hiv, vacc, developed, genvec

NIH initiates Ph I of HIV vacc developed with GenVec

Article | 31 January 2005

Print This

The USA's National Institute of Allergy and Infectious Diseases has commenced a second Phase I clinical trial of an HIV ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in